insights_auto
Why is DNA down 2,09%?
Dive Deeperchevron_right
DNA:NYSE
Ginkgo Bioworks Holdings Inc
US$9,86
arrow_downward
-2,09%(-0,21) 1D
US$9,86
0,00% (0,00)
bedtimeAfter hours
Closed: 20 ຕ.ລ., 16 ໂມງ 0 ນາທີ 04 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DNA...
Open
US$10,12
High
US$10,38
Low
US$9,85
Mkt. cap
634,40 ລ້ານ
Avg. vol.
3,00 ລ້ານ
Volume
2,48 ລ້ານ
52-wk high
US$18,22
52-wk low
US$5,37
EPS
US$-5,00
Beta
1,79
Shares outstanding
55,38 ລ້ານ
No. of employees
485
Open
US$10,12
High
US$10,38
Low
US$9,85
Mkt. cap
634,40 ລ້ານ
Avg. vol.
3,00 ລ້ານ
Volume
2,48 ລ້ານ
52-wk high
US$18,22
52-wk low
US$5,37
EPS
US$-5,00
Beta
1,79
Shares outstanding
55,38 ລ້ານ
No. of employees
485
News stories
From web sources and news partners
Investing.com Canada
·
11 ຊົ່ວໂມງກ່ອນ
Form 144 Ginkgo Bioworks Holdings For: 20 October By Investing.com
Profile
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
About Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Employees485
Founded2008
Headquartersບອສຕັນ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorHealth care
Websiteginkgo.bio